The authors outline cell-line development and process scale-up for an antibody program in which the antibody requires additional processing by a site-specific enzyme for correct functionality.
David Rabuka
Advertisement
Articles by David Rabuka
Advertisement
Latest Updated Articles
Generating a Fully Processed AntibodyPublished: September 1st 2016 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Q&A: An Evolution in Enzyme Engineering with Zymvol’s Marina Cañellas
2
AI-Driven Organ-on-Chip Platforms Are Changing the Game in Bio/Pharma R&D
3
Regulatory Challenges for Global Manufacturing of Vaccines
4
Novartis–Avidity Biosciences Deal Highlights Next-Gen RNA Manufacturing Potential
5
